Xoma Series B Preferred Stock

XOMAO

Overview Fund Trends Analyst Outlook Journalist POV

25.44 USD

--0.01

0.04%

At close Updated Oct 31, 11:39 AM EDT

1 day

-0.04%

5 days

-0.16%

1 month

-0.2%

3 months

-0.93%

6 months

0.47%

Year to date

-0.7%

1 year

-0.63%

5 years

3.08%

10 years

3.08%

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Employees: 13

Healthcare Biotechnology

–

Funds holding %

of 7,505 funds

Explore Fund Trends

–

Analysts bullish %

See Analyst Outlook

–

Positive news %

Check Journalist POV